ACUT
Price
$0.90
Change
-$0.02 (-2.17%)
Updated
Jul 10 closing price
Capitalization
14.83M
KMSTF
Price
$5.06
Change
-$0.04 (-0.78%)
Updated
Mar 18 closing price
Capitalization
30.45M
Interact to see
Advertisement

ACUT vs KMSTF

Header iconACUT vs KMSTF Comparison
Open Charts ACUT vs KMSTFBanner chart's image
Accustem Sciences
Price$0.90
Change-$0.02 (-2.17%)
Volume$3.61K
Capitalization14.83M
KADIMASTEM
Price$5.06
Change-$0.04 (-0.78%)
Volume$150
Capitalization30.45M
ACUT vs KMSTF Comparison Chart in %
Loading...
ACUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACUT vs. KMSTF commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACUT is a Hold and KMSTF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (ACUT: $0.90 vs. KMSTF: $5.06)
Brand notoriety: ACUT and KMSTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACUT: 85% vs. KMSTF: 100%
Market capitalization -- ACUT: $14.83M vs. KMSTF: $30.45M
ACUT [@Biotechnology] is valued at $14.83M. KMSTF’s [@Biotechnology] market capitalization is $30.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACUT’s FA Score shows that 1 FA rating(s) are green whileKMSTF’s FA Score has 0 green FA rating(s).

  • ACUT’s FA Score: 1 green, 4 red.
  • KMSTF’s FA Score: 0 green, 5 red.
According to our system of comparison, ACUT is a better buy in the long-term than KMSTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACUT’s TA Score shows that 4 TA indicator(s) are bullish.

  • ACUT’s TA Score: 4 bullish, 5 bearish.

Price Growth

ACUT (@Biotechnology) experienced а -0.33% price change this week, while KMSTF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KMSTF($30.4M) has a higher market cap than ACUT($14.8M). ACUT YTD gains are higher at: 100.223 vs. KMSTF (-20.987). ACUT has higher annual earnings (EBITDA): -1.42M vs. KMSTF (-9.53M). ACUT (0) and KMSTF (0) have equivalent revenues.
ACUTKMSTFACUT / KMSTF
Capitalization14.8M30.4M49%
EBITDA-1.42M-9.53M15%
Gain YTD100.223-20.987-478%
P/E RatioN/AN/A-
Revenue00-
Total Cash36.4KN/A-
Total Debt57.6KN/A-
TECHNICAL ANALYSIS
Technical Analysis
ACUTKMSTF
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 2 days ago
7%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 2 days ago
5%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
80%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ACUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
THXPF0.55N/A
+0.57%
THOR EXPLORATION LTD.
ELMA21.00N/A
N/A
Elmer Bancorp, Inc.
SHTDF2.21N/A
N/A
Sinopharm Group Co. Ltd.
KPLIF0.27N/A
N/A
Keppel Infrastructure Trust
AFNL171.92N/A
N/A
Amfin Financial Corp.

ACUT and

Correlation & Price change

A.I.dvisor tells us that ACUT and KMSTF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACUT and KMSTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACUT
1D Price
Change %
ACUT100%
-2.82%
KMSTF - ACUT
28%
Poorly correlated
N/A
MOLN - ACUT
21%
Poorly correlated
-0.84%
PHGE - ACUT
20%
Poorly correlated
-2.38%
TELIF - ACUT
11%
Poorly correlated
+4.26%
BLTE - ACUT
11%
Poorly correlated
-3.32%
More

KMSTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, KMSTF has been loosely correlated with IRON. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if KMSTF jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMSTF
1D Price
Change %
KMSTF100%
N/A
IRON - KMSTF
54%
Loosely correlated
+3.83%
ZVRA - KMSTF
30%
Poorly correlated
+3.98%
ACUT - KMSTF
28%
Poorly correlated
-2.82%
SRZN - KMSTF
28%
Poorly correlated
+3.00%
BLRX - KMSTF
24%
Poorly correlated
-0.81%
More